Why Insulin Resistance Makes Semaglutide and Tirzepatide Work Against You — What Your Fasting Insulin Level Actually Reveals About Your GLP-1 Response

If you’ve been asking why semaglutide isn’t working the way you expected — or why tirzepatide delivered results for a few months before everything slowed to a crawl — you’re not imagining it. And the answer almost certainly isn’t willpower, effort, or dose. For a significant portion of patients on GLP-1 medications, the hidden barrier is insulin resistance, and the test that would reveal it is one most online prescribers never order.

The Real Reason GLP-1 Medications Don’t Work the Same for Everyone

GLP-1 receptor agonists like semaglutide and tirzepatide are powerful tools. They suppress appetite, slow gastric emptying, and help regulate blood sugar — all of which support meaningful weight loss for millions of patients. But they don’t work in isolation. They work within the context of your metabolic health.

When your body’s insulin signaling system is dysregulated — a condition called insulin resistance — the entire landscape changes. Cells stop responding properly to insulin’s signals. Your pancreas compensates by producing more. Blood sugar swings become wider. Fat storage grows stubborn, especially around the abdomen. And your body’s ability to burn stored fat for fuel decreases significantly.

GLP-1 medications can only do so much when they’re fighting upstream metabolic dysfunction. That’s why two patients on the same medication and the same dose can have dramatically different outcomes.

The Fasting Insulin Test: The Lab Most Online Prescribers Skip

Standard metabolic panels typically include fasting glucose and HbA1c. These are useful, but they’re lagging indicators. By the time fasting glucose is elevated or A1c creeps upward, insulin resistance has often been present — and quietly worsening — for years.

The test that catches insulin resistance early is fasting insulin. It measures how much insulin your pancreas is secreting first thing in the morning before any food. A fasting insulin level that falls within the “normal” lab reference range can nonetheless be elevated enough to signal serious metabolic dysfunction.

Most telehealth and online GLP-1 prescribers never order this test. They check glucose. They check A1c. They write the prescription. But without understanding your insulin levels, they’re working with an incomplete picture — and so are you.

What Is HOMA-IR and Why It Matters for Weight Loss

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a calculation derived from your fasting glucose and fasting insulin values. It gives a clearer snapshot of how well your body’s insulin signaling is actually functioning.

A HOMA-IR above 2.0 suggests developing insulin resistance. Above 2.9 indicates meaningful resistance that will likely impact your metabolism and your GLP-1 response. Many functional medicine providers prefer HOMA-IR over either value alone — it connects the dots in a way that neither measurement can do independently.

For patients struggling with a semaglutide plateau or a tirzepatide plateau, HOMA-IR is often one of the first places to look.

What “Normal” on Your Labs Doesn’t Actually Tell You

Lab reference ranges are calibrated to the general population — which, statistically, is not metabolically healthy. A fasting insulin of 15 µIU/mL might fall within your lab’s reference range, but optimal metabolic function is typically associated with fasting insulin below 8–10 µIU/mL.

This is where standard care often fails patients. A provider glances at the reference range, sees no red flags, and assumes the metabolic foundation is solid. In reality, the patient may be in a zone of subclinical insulin resistance that’s actively working against their weight loss progress — and no one is telling them.

How Insulin Resistance Sabotages Your GLP-1 Response

Here’s the mechanism most patients never hear explained:

  • Chronic high insulin signals fat storage. When insulin is persistently elevated, your body receives a continuous signal to store energy rather than burn it. GLP-1 medications reduce appetite, but they cannot fully override an insulin environment wired for fat accumulation.
  • Blunted glucose response. Insulin-resistant patients often experience more dramatic blood sugar fluctuations, which drive hunger cycles and cravings that persist even on GLP-1 therapy.
  • Inflammation and cortisol feedback. Insulin resistance is closely linked to low-grade systemic inflammation and cortisol dysregulation — both of which further suppress fat burning and blunt the appetite-suppressing effects of GLP-1 medications.
  • Thyroid-insulin crosstalk. Insulin resistance can impair thyroid hormone conversion, slowing your metabolic rate independently of your GLP-1 dose. If T3 conversion is compromised, you can be on the maximum dose of semaglutide and still hit a wall.

None of these mechanisms appear on a basic metabolic panel. And none will resolve by simply increasing your dose.

Signs You Might Be an Insulin-Resistant GLP-1 Poor Responder

You don’t need a lab result to suspect insulin resistance. These patterns are common warning signs:

  • Strong carbohydrate or sugar cravings, especially mid-afternoon
  • Fatigue after meals, particularly after eating carbohydrates
  • Difficulty losing belly fat even with caloric restriction
  • Weight loss that stalled after 2–4 months on semaglutide or tirzepatide
  • Energy crashes between meals
  • Waist circumference above 35 inches (women) or 40 inches (men)
  • A personal or family history of PCOS, prediabetes, or type 2 diabetes

If several of these apply to you and you’re experiencing what looks like a GLP-1 poor responder pattern, insulin resistance is likely part of the explanation.

What to Do When Semaglutide or Tirzepatide Stops Working

The first step may not be a higher dose. It may be better data.

When GLP-1 stops working or weight comes back, the answer is often in the blood work. Made Ya Skinny takes a functional medicine approach — running the right labs, reading them correctly, and building a plan around what your body actually needs rather than just increasing the dose.

That means ordering fasting insulin alongside fasting glucose. It means calculating HOMA-IR. It means checking a full thyroid panel with free T3 and reverse T3, not just TSH. It means examining cortisol patterns, inflammatory markers like hs-CRP, and nutrient status — including magnesium, vitamin D, and B12 — all of which directly affect insulin sensitivity and GLP-1 response.

Once that picture is clear, real interventions become possible: targeted nutritional adjustments, meal timing strategies that reduce insulin spikes, and physician-supervised modifications to your GLP-1 therapy grounded in your actual physiology rather than guesswork.

For patients with insulin resistance, BHRT (bioidentical hormone replacement therapy) is sometimes part of the correction. Estrogen, progesterone, and testosterone all play roles in insulin sensitivity — and in women between 35 and 55, hormonal shifts can be a primary driver of both insulin resistance and GLP-1 plateau. Addressing the hormone deficiency while continuing GLP-1 therapy often unlocks results the medication alone could never produce.

Medical Weight Loss in Magnolia, TX That Looks at the Full Picture

At Made Ya Skinny, physician-supervised GLP-1 weight loss is never a one-size-fits-all prescription. Our approach to medical weight loss in Magnolia, TX — and through telehealth across Texas and multiple states — starts with understanding your metabolic baseline before assuming the medication isn’t working.

If you’re in Cypress, The Woodlands, Conroe, Willis, Montgomery, Tomball, or anywhere in the North Houston area and you’re frustrated with a plateau or a program that isn’t delivering, you deserve an evaluation that goes deeper than a basic panel and a default dose increase.

GLP-1 medications are powerful — but only when your metabolic foundation supports them. Understanding your insulin levels, your hormones, and your inflammatory load is what separates a program that works long-term from one that stalls at month three.

If you’re ready to find out what’s actually happening in your body and build a functional medicine weight loss plan that addresses it directly, visit madeyaskinny.com to schedule your consultation. No surgery. No downtime. Just real, physician-guided answers.

This article is general health information, not medical advice, and does not create a provider-patient relationship. Individual results will vary. Talk with your provider before starting, stopping, or changing any medication.